| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000047644 |
| Receipt No. | R000054244 |
| Scientific Title | Observation study of psychiatric symptoms in patients admitted to sterile rooms with hematopoietic cell transplantation |
| Date of disclosure of the study information | 2022/05/15 |
| Last modified on | 2022/05/02 (Ver. 1) |
| Basic information | ||
| Public title | Multicenter collaborative research on psychiatric symptoms of hematopoietic cell transplantation -Longitudinal study on entry and exit from sterile room and long-term prognosis- | |
| Acronym | Multicenter collaborative research on psychiatric symptoms of hematopoietic cell transplantation -Longitudinal study on entry and exit from sterile room and long-term prognosis- | |
| Scientific Title | Observation study of psychiatric symptoms in patients admitted to sterile rooms with hematopoietic cell transplantation | |
| Scientific Title:Acronym | Observation study (Longitudinal study) | |
| Region |
|
|
| Condition | ||
| Condition | hematological cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the factors that predict psychiatric symptoms during and after entering and leaving the sterile room of patients undergoing hematopoietic stem cell transplantation. |
| Basic objectives2 | Others |
| Basic objectives -Others | To clarify the factors that associated with psychiatric symptoms during and after entering and leaving the sterile room of patients undergoing hematopoietic stem cell transplantation. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | CESD (The Center for Epidemiology Studies Depression scale) was performed before entering the sterile room, during entering the room, at the time of leaving the room, and 3, 6 and 12 months after leaving the room. |
| Key secondary outcomes | - POMS2 (Profile of Mood States 2nd Edition) was performed before entering the sterile room, during entering the room, at the time of leaving the room, and 3, 6 and 12 months after leaving the room.
- Before entering the sterile room, SCID (Structured Clinical Interview for DSM-4 AXIS I Disorders), INTERMED, and MAC (Mental Adjustment to Cancer) were performed. - GHQ30 (The General Health Questionnaire) was performed 3, 6 and 12 months after leaving the room. - MMSE (Mini Mental State Examination) was performed before entering the sterile room and 12 months after leaving the room. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Patients over 20 years old
(2) Patients who have received sufficient explanation in participating in this research and obtained written consent at their own free will. (3) Patients planning the first hematopoietic stem cell transplant for hematopoietic cancer (less than 5 points in Hematopoietic Cell Transplantation-Comorbidity Index) |
|||
| Key exclusion criteria | (1) Patients with consciousness disturbance or severe dementia
(2) Patients who have difficulty in evaluating by questionnaire or interview because their physical symptoms are severe. (3) Patients with speech / hearing or visual impairment that affect understanding of the method in the evaluation (4) Patients with psychiatric disorders other than depression, such as schizophrenia (5) Others who are judged to be inappropriate by the principal investigator or the co-investigator |
|||
| Target sample size | 70 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokai University | ||||||
| Division name | School of Medicine, Department of Psychiatry | ||||||
| Zip code | 259-1193 | ||||||
| Address | 143 Shimokasuya, Isehara, Kanagawa, 259-1193 Japan | ||||||
| TEL | +81463931121 | ||||||
| key@is.icc.u-tokai.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokai University | ||||||
| Division name | School of Medicine, Department of Psychiatry | ||||||
| Zip code | 259-1193 | ||||||
| Address | 143 Shimokasuya, Isehara, Kanagawa, 259-1193 Japan | ||||||
| TEL | +81463931121 | ||||||
| Homepage URL | |||||||
| key@is.icc.u-tokai.ac.jp | |||||||
| Sponsor | |
| Institute | Tokai University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kurashiki Central Hospital
|
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board for Clinical Research, Tokai University |
| Address | 143 Shimokasuya, Isehara, Kanagawa, 259-1193 Japan |
| Tel | +81463931121 |
| tokai-rinsho@ml.tokai-u.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 2546 |
| Org. issuing International ID_1 | Kurashiki Central Hospital |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東海大学医学部付属病院、倉敷中央病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | ||
| URL related to results and publications | ||
| Number of participants that the trial has enrolled | 70 | |
| Results | ||
| Results date posted | ||
| Results Delayed |
|
|
| Results Delay Reason | Data analysis is delayed. | |
| Date of the first journal publication of results | ||
| Baseline Characteristics | ||
| Participant flow | ||
| Adverse events | ||
| Outcome measures | ||
| Plan to share IPD | ||
| IPD sharing Plan description | ||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Several scales made it possible to predict depression measured by CES-D when leaving the sterile room. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054244 |